EA200200033A1 - METHOD OF TREATING VIRAL HEPATITIS - Google Patents

METHOD OF TREATING VIRAL HEPATITIS

Info

Publication number
EA200200033A1
EA200200033A1 EA200200033A EA200200033A EA200200033A1 EA 200200033 A1 EA200200033 A1 EA 200200033A1 EA 200200033 A EA200200033 A EA 200200033A EA 200200033 A EA200200033 A EA 200200033A EA 200200033 A1 EA200200033 A1 EA 200200033A1
Authority
EA
Eurasian Patent Office
Prior art keywords
energy
reflexotherapy
hepatobiliary
organs
viral hepatitis
Prior art date
Application number
EA200200033A
Other languages
Russian (ru)
Other versions
EA005044B1 (en
Inventor
Виктор Геннадьевич Соломатов
Анна Викторовна Соломатова
Мария Викторовна Соломатова
Галина Владимировна Соломатова
Геннадий Сергеевич Соломатов
Галина Дмитриевна Соломатова
Original Assignee
ООО "Медицинский центр доктора Соломатова"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ООО "Медицинский центр доктора Соломатова" filed Critical ООО "Медицинский центр доктора Соломатова"
Priority to EA200200033A priority Critical patent/EA005044B1/en
Publication of EA200200033A1 publication Critical patent/EA200200033A1/en
Publication of EA005044B1 publication Critical patent/EA005044B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретение относится к медицине, точнее к энергорефлексотерапии и может быть использовано для лечения заболеваний, связанных с вирусными поражениями гепатобилиарной системы и сопряженных органов. Способ заключается в воздействии на значимые БАТ и/или зоны энергорефлексотерапии, отвечающие за нормализацию энергетического состояния гепатобилиарной системы, и/или иммунной системы, и/или нервной системы и сопряженных с ними органов, при этом в качестве сопряженных органов берут поджелудочную железу, тонкий и толстый кишечник, мочевыделительную систему, половые органы, элементы опорно-двигательного аппарата, эндокринные железы, а топологию воздействия связывают с периодами лунного месяца, полнолуния и новолуния, а также временем суток. Учитывается энерготип пациента.The invention relates to medicine, more specifically to energy reflexotherapy and can be used for the treatment of diseases associated with viral lesions of the hepatobiliary system and related organs. The method consists in influencing the significant BAT and / or energy reflexotherapy zones responsible for the normalization of the energy state of the hepatobiliary system and / or the immune system and / or the nervous system and organs associated with them, while the pancreas, the thin and the large intestine, urinary system, genitals, elements of the musculoskeletal system, endocrine glands, and the topology of the impact is associated with periods of the lunar month, full moon and new moon, as well as su current. The patient's energy type is taken into account.

EA200200033A 2001-10-08 2001-10-08 Method for treating viral hepatitis EA005044B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA200200033A EA005044B1 (en) 2001-10-08 2001-10-08 Method for treating viral hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA200200033A EA005044B1 (en) 2001-10-08 2001-10-08 Method for treating viral hepatitis

Publications (2)

Publication Number Publication Date
EA200200033A1 true EA200200033A1 (en) 2003-04-24
EA005044B1 EA005044B1 (en) 2004-10-28

Family

ID=34072395

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200033A EA005044B1 (en) 2001-10-08 2001-10-08 Method for treating viral hepatitis

Country Status (1)

Country Link
EA (1) EA005044B1 (en)

Also Published As

Publication number Publication date
EA005044B1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
DE69733132D1 (en) USE OF ANTIOXIDANTS FOR THE TREATMENT OF CHOLESTATIVE LIVER DISEASES
DK0880350T3 (en) Treatment of disseminated sclerosis
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
NO971355L (en) Photodynamic Therapy in Selective Cell Inactivation in Blood and Treatment of Immune Dysfunction Diseases
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
ATE266417T1 (en) MEDICATIONS FOR PREVENTING OR TREATING VASCULAR HEMORRHAGIA
IL132798A0 (en) Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
DK1112084T4 (en) Combination treatments of B-cell lymphomas comprising administration of anti-CD20 antibodies
ATE232396T1 (en) OXIDATED THYMOSINE BETA 4
HK1071687A1 (en) Pharmaceutical preparation and method of treatmentof human malignancies with arginine deprivation
ATE258796T1 (en) USE OF VITAMIN D4 DERIVATIVES TO TREAT SKIN DISEASES
ATE247709T1 (en) 3'UTR OF THE HUMAN PROHIBITIN GENE
ATE453402T1 (en) USE OF SERP-1 IN COMBINATION WITH AN IMMUNOSUPPRESSOR TO TREAT ARTHRITIS
DE69829202D1 (en) USE OF MIRTAZAPINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SLEEP APNOES
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
TR200200278T2 (en) Calcilitic compositions
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
EA200200033A1 (en) METHOD OF TREATING VIRAL HEPATITIS
DK1251850T3 (en) Use of a combination preparation in cancer treatment
DE69132682D1 (en) CELL GROWTH INHIBITORS
HUP9904669A3 (en) Therapeutic applications of t-bam(cd40l)technology to treat diseases involving smooth muscle cells
ATE306278T1 (en) TREATING BONE DISEASES WITH ADRENOMEDULLIN
EP0668771A4 (en) Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs.
DK0859630T3 (en) Combination of thermozolomide and alpha IFN for the treatment of advanced cancer
EA200200456A1 (en) METHOD OF TREATING DISEASES ASSOCIATED WITH ENDOCRINE SYSTEM DISORDERS

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU